Report overview
Peritoneal cancer is also known as serous surface papillary carcinoma, primary peritoneal carcinoma, extra-ovarian serous carcinoma, primary serous papillary carcinoma and psammomacarcinoma.
This report contains market size and forecasts of Peritoneal Cancer in Global, including the following market information:
Global Peritoneal Cancer Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Peritoneal Cancer market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Surgery Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Peritoneal Cancer include AstraZeneca, GlaxoSmithKline, Oxford BioMedica, Millennium Pharmaceuticals, Novartis, Bayer, Incyte, EntreMed and Oncolytics Biotech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Peritoneal Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peritoneal Cancer Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Peritoneal Cancer Market Segment Percentages, by Type, 2021 (%)
Surgery
Chemotherapy (Anticancer Drugs)
Radiotherapy (High-Energy Rays)
Global Peritoneal Cancer Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Peritoneal Cancer Market Segment Percentages, by Application, 2021 (%)
Cancer Research Centers
Cancer Hospital
Surgical Centers
Clinics
Global Peritoneal Cancer Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Peritoneal Cancer Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Peritoneal Cancer revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Peritoneal Cancer revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
GlaxoSmithKline
Oxford BioMedica
Millennium Pharmaceuticals
Novartis
Bayer
Incyte
EntreMed
Oncolytics Biotech
Synta Pharmaceuticals
Oasmia Pharmaceutical
